{"id":"W4365479293","doi":"10.1182/bloodadvances.2023009781","title":"Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; CTI Biopharma; Incyte; Sierra Oncology; Celgene; MorphoSys; Servier; Astellas Pharma; Syndax Pharmaceuticals; Gilead Sciences; Bristol-Myers Squibb; Agios Pharmaceuticals","keywords":"Myelodysplastic syndromes; Anemia; Medicine; Oncology; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002875954,0.0003034391,0.0009098467,0.0002728782,0.0001400279,0.0003705392,0.0002921843,0.0002542907,0.001973404],"category_scores_gemma":[0.0002676086,0.0000963963,0.0005245526,0.0002554106,0.0001383399,0.0002793563,0.0001479836,0.00122882,0.0003386698],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002536183,"about_ca_system_score_gemma":0.0003575471,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003293263,"about_ca_topic_score_gemma":0.001022342,"domain_scores_codex":[0.9998688,0.00003881042,0.0000136986,0.00001850725,0.00002767296,0.00003256836],"domain_scores_gemma":[0.9999189,0.00001581326,0.00001865384,0.000005008742,0.000008923277,0.00003266923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1010273,0.005549724,0.01058518,0.001590119,0.00171274,0.00130195,0.0001435976,0.003570081,0.1043945,0.0008829164,0.01017924,0.7590626],"study_design_scores_gemma":[0.1402431,0.2921872,0.2407521,0.0007034536,0.007562941,0.01584378,0.0003785577,0.02004126,0.1344153,0.002318394,0.1452734,0.0002806862],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9366219,0.05276357,0.001047116,0.0009819677,0.0003430049,0.0001871268,0.0006089502,0.0002193883,0.007226971],"genre_scores_gemma":[0.9901361,0.005754773,0.0009531379,0.000449295,0.0001374253,0.000070476,0.0007415135,0.000009708085,0.001747718],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001973404,"threshold_uncertainty_score":0.006601632,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02239236770013055,"score_gpt":0.3198697072487417,"score_spread":0.2974773395486112,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}